Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Oct 11, 2022 2:39pm
RE:Put pressure on the company
Hard to understand the decision making process at IMV.I emailed them but got a responce that they couldn't provide details due to upcoming conference presentation.They did not indicate which
...more
(2)
•••
bikkel78
X
View Profile
View Bullboard History
Post by
bikkel78
on Oct 05, 2022 2:52am
Put pressure on the company
Sad to see they made the decision to save the prelim DLBCL data for a conference. Seems like they prefer scientists over shareholders. Time for action. Please send a mail to ddavan@imv-inc.com or
...more
(18)
•••
antisense
X
View Profile
View Bullboard History
Comment by
antisense
on Sep 30, 2022 10:36am
RE:RE:VITALIZE Update!!??
I hope you are right. They lead investors to beleive the first round of early results would be released end of Q3 2022 in their: Second Quarter 2022 Financial and Operational Results "
...more
(2)
•••
bikkel78
X
View Profile
View Bullboard History
Comment by
bikkel78
on Sep 30, 2022 10:04am
RE:VITALIZE Update!!??
IMV is announcing that they will present the data in a scientific conference early 2023 which is to be seen as a positive news. Unfortunately these conferences do not accept presentations
...more
(18)
•••
antisense
X
View Profile
View Bullboard History
Post by
antisense
on Sep 30, 2022 9:56am
VITALIZE Update!!??
What kind of trial update was that??!! "We are providing an Update on the VITALIZE trial in order to check off the box that we said we'd provide ann update on the VITALIZE trial around
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 30, 2022 7:06am
New Press Release - IMV Provides an Update on The VITALIZE Trial
Enrollment has accelerated in the last quarter, reflecting enthusiasm for this novel treatment optionData to be presented at a scientific conference in early 2023 IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies...
read article.
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Sep 29, 2022 3:43pm
dlbcl data 3Q
any results reported in next few days are likely so preliminary that mrkt's going to be less than enthused. Just too early for meaningful data.
(2)
•••
europe10
X
View Profile
View Bullboard History
Post by
europe10
on Sep 29, 2022 12:10pm
last chance?
Tic tac, DLBCL results should be out soon, or? "3rd quarter" Hmmmmm 7/8 patients reported ORR before If IMV can repeat that, or close to those figures, it will be superb results. That
...more
(0)
•••
Aimvex
X
View Profile
View Bullboard History
Post by
Aimvex
on Sep 18, 2022 11:16am
Imv restructuring
Imv has laid off 30% of It's work force calling it strategical restructuring. In my perspective leader of this company doesn't know what he is doing and where they are headed.!
(2)
•••
Breakthorough
X
View Profile
View Bullboard History
Post by
Breakthorough
on Sep 17, 2022 4:53am
Interview
This interview with Matasar (in charge of VITALIZE trial) looks pretty optimistic. I would highlight this, because he calls VITALIZE a PIVOTAL trial: "This is a pivotal clinical trial that we
...more
(1)
•••
JoefromDC
X
View Profile
View Bullboard History
Comment by
JoefromDC
on Sep 16, 2022 11:25am
RE:Anyone buying IMV today will double their money easy.
That's good cause I already lost half
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 15, 2022 7:45am
New Press Release - IMV Inc. Announces Strategic Reorganization
Reorganization enhances organizational focus on strategic prioritiesClinical update on DLBCL patients in Phase 2B VITALIZE trial to be provided in SeptemberAppointment of Dr. Saman Maleki to Board of DirectorsBrittany Davison promoted to Chief Accounting Officer IMV Inc. (Nasdaq: IMV; TSX: IMV)...
read article.
(38)
•••
driller1a
X
View Profile
View Bullboard History
Post by
driller1a
on Sep 14, 2022 3:58pm
Anyone buying IMV today will double their money easy.
More than likely by the end of this year.
(2)
•••
Breakthorough
X
View Profile
View Bullboard History
Comment by
Breakthorough
on Sep 12, 2022 10:49am
RE:RE:RE:RE:RE:RE:RE:RE:Interesting (and hidden) data
It is here: https://www.imv-inc.com/the-dpx-platform/scientific-publications-posters
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Sep 12, 2022 10:45am
RE:RE:RE:RE:RE:RE:RE:Interesting (and hidden) data
Thanks Breakthrough.The wording on their tweet was what confused me.If it was just a repeat of the August 22 presentation,there would be no new info given in the ESMO presentation. Is the PDF you
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income